Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
αDC1 Vaccine + CKM in Metastatic Colorectal Cancer
NCT02615574Phase 2Withdrawn
- Start
- Mar 2016
- Primary completion
- Jun 2018
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-type-1-polarized dendritic cell vaccine in colorectal cancer (CRC). Planned start Mar 2016; status: withdrawn.
02
Drugs
alpha-type-1-polarized dendritic cell vaccine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02615574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615574.